148 related articles for article (PubMed ID: 9676170)
1. Atherosclerosis prevention for the next decade: risk assessment beyond low density lipoprotein cholesterol.
Lamarche B; Lewis GF
Can J Cardiol; 1998 Jun; 14(6):841-51. PubMed ID: 9676170
[TBL] [Abstract][Full Text] [Related]
2. A prospective, population-based study of low density lipoprotein particle size as a risk factor for ischemic heart disease in men.
Lamarche B; St-Pierre AC; Ruel IL; Cantin B; Dagenais GR; Després JP
Can J Cardiol; 2001 Aug; 17(8):859-65. PubMed ID: 11521128
[TBL] [Abstract][Full Text] [Related]
3. The small, dense LDL phenotype and the risk of coronary heart disease: epidemiology, patho-physiology and therapeutic aspects.
Lamarche B; Lemieux I; Després JP
Diabetes Metab; 1999 Sep; 25(3):199-211. PubMed ID: 10499189
[TBL] [Abstract][Full Text] [Related]
4. Triglycerides, high-density lipoprotein cholesterol, and risk of ischemic heart disease: a view from the Copenhagen Male Study.
Jeppesen J
Metab Syndr Relat Disord; 2003 Mar; 1(1):33-53. PubMed ID: 18370624
[TBL] [Abstract][Full Text] [Related]
5. The lipid triad in type 2 diabetes - prevalence and relevance of hypertriglyceridaemia/low high-density lipoprotein syndrome in type 2 diabetes.
Temelkova-Kurktschiev T; Hanefeld M
Exp Clin Endocrinol Diabetes; 2004 Feb; 112(2):75-9. PubMed ID: 15031770
[TBL] [Abstract][Full Text] [Related]
6. Management of hypercholesterolaemia in the patient with diabetes.
Packard C; Olsson AG
Int J Clin Pract Suppl; 2002 Jul; (130):27-32. PubMed ID: 12296606
[TBL] [Abstract][Full Text] [Related]
7. Rising to the challenge of the new NCEP ATP III guidelines: exceeding current therapeutic limitations.
Brewer HB
Am J Manag Care; 2002 Feb; 8(2 Suppl):S23-8; discussion S45-7. PubMed ID: 11855698
[TBL] [Abstract][Full Text] [Related]
8. Statins and diabetes.
Carmena R; Betteridge DJ
Semin Vasc Med; 2004 Nov; 4(4):321-32. PubMed ID: 15861314
[TBL] [Abstract][Full Text] [Related]
9. Insulin resistance, the insulin resistance syndrome, and cardiovascular disease.
Reaven GM
Panminerva Med; 2005 Dec; 47(4):201-10. PubMed ID: 16489319
[TBL] [Abstract][Full Text] [Related]
10. Is there a simple way to identify insulin-resistant individuals at increased risk of cardiovascular disease?
McLaughlin T; Reaven G; Abbasi F; Lamendola C; Saad M; Waters D; Simon J; Krauss RM
Am J Cardiol; 2005 Aug; 96(3):399-404. PubMed ID: 16054467
[TBL] [Abstract][Full Text] [Related]
11. Niacin-based therapy for dyslipidemia: past evidence and future advances.
Ito MK
Am J Manag Care; 2002 Sep; 8(12 Suppl):S315-22. PubMed ID: 12240703
[TBL] [Abstract][Full Text] [Related]
12. Inter-relationships between small, dense low-density lipoprotein (LDL), plasma triacylglycerol and LDL apoprotein B in an atherogenic lipoprotein phenotype in free-living subjects.
Griffin BA; Minihane AM; Furlonger N; Chapman C; Murphy M; Williams D; Wright JJ; Williams CM
Clin Sci (Lond); 1999 Sep; 97(3):269-76. PubMed ID: 10464051
[TBL] [Abstract][Full Text] [Related]
13. Lability of serum low-density lipoprotein cholesterol levels during screening in subgroup of Air Force/Texas Coronary Atherosclerosis Prevention Study (AFCAPS/TexCAPS) cohort.
Clearfield MB; Weis SE; Willis JM; Vasenius KA; McConathy WJ
J Am Osteopath Assoc; 2002 Jul; 102(7):377-84. PubMed ID: 12138952
[TBL] [Abstract][Full Text] [Related]
14. High-density lipoprotein cholesterol and triglycerides as therapeutic targets for preventing and treating coronary artery disease.
Gotto AM
Am Heart J; 2002 Dec; 144(6 Suppl):S33-42. PubMed ID: 12486414
[TBL] [Abstract][Full Text] [Related]
15. Effects of modifying triglycerides and triglyceride-rich lipoproteins on cardiovascular outcomes.
Abdel-Maksoud M; Sazonov V; Gutkin SW; Hokanson JE
J Cardiovasc Pharmacol; 2008 Apr; 51(4):331-51. PubMed ID: 18427276
[TBL] [Abstract][Full Text] [Related]
16. Role of lipid and lipoprotein profiles in risk assessment and therapy.
Ballantyne CM; Hoogeveen RC
Am Heart J; 2003 Aug; 146(2):227-33. PubMed ID: 12891189
[TBL] [Abstract][Full Text] [Related]
17. Prevalence of high plasma triglyceride combined with low HDL-C levels and its association with smoking, hypertension, obesity, diabetes, sedentariness and LDL-C levels in the Canadian population. Canadian Heart Health Surveys Research Group.
Connelly PW; Petrasovits A; Stachenko S; MacLean DR; Little JA; Chockalingam A
Can J Cardiol; 1999 Apr; 15(4):428-33. PubMed ID: 10322252
[TBL] [Abstract][Full Text] [Related]
18. Risk determination of dyslipidemia in populations characterized by low levels of high-density lipoprotein cholesterol.
Bersot TP; Pépin GM; Mahley RW
Am Heart J; 2003 Dec; 146(6):1052-9. PubMed ID: 14660998
[TBL] [Abstract][Full Text] [Related]
19. High blood cholesterol.
National Heart, Lung and Blood Institute
Nutr Clin Care; 2003; 6(3):108-14. PubMed ID: 14979453
[TBL] [Abstract][Full Text] [Related]
20. [The "second atherogenic phenotype" or the role of insulin resistance in vascular risk].
Ziegler O; Guerci B; Drouin P
Arch Mal Coeur Vaiss; 1998 Oct; 91 Spec No 5():33-9. PubMed ID: 9833078
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
